AbbVie, Inc. ABBV announced that it is discontinuing development of its small-cell lung cancer (SCLC) candidate rovalpituzumab tesirine or Rova-T after failure of the third study, MERU. The phase III ...

Rova Saxophone Quartet Bop Stop at the Music Settlement Cleveland, OHOctober 4, 2022 One of the inescapable trends in music over the last decade has been the convergence of two traditions in ...

AbbVie’s once-highly lauded cancer drug Rova-T, bought from a $5.8 billion deal with Stemcentrx in 2016, will cost the company an additional $4 billion in an impairment charge as the woe keeps coming ...

Richard Staines discusses what has become one of the worst deals in pharma’s history – AbbVie’s purchase of Stemcentrx and its lung cancer drug Rova-T. Rova-T was supposed to be the cancer drug that ...

AbbVie’s Rova-T has failed yet another lung cancer trial, this time as a frontline treatment. But AbbVie didn’t regroup and point to its Rova-T programs in other treatment settings. It axed the drug, ...

When the ROVA selfie drone was displayed at CES, I was so impressed with its wallet-friendly price point of $399 and the HD camera that it made it into my top drones to watch for 2017 list. Selfie ...

Ironically, the highest forms of freedom require the greatest discipline. And so it is with the ROVA saxophone quartet, rejuvenated in their earliest form on this '81 reissue. As Was documents the ...

“Lately I’ve been feeling … that there is a right path for each improv from beginning to end and you’re trying to find that path.” –Steve Adams, Rova Saxophone Quartet In the Spark episode “The Art of ...